Impaired Pulmonary Function in Patients with Psoriasis
dc.contributor.author | Baki, Didem Didar | |
dc.contributor.author | Celik, Ebru | |
dc.contributor.author | Genc, Sebahat | |
dc.contributor.author | Celik, Muhammet Murat | |
dc.contributor.author | Inan, Mehmet Ugur | |
dc.date.accessioned | 2024-09-18T20:55:32Z | |
dc.date.available | 2024-09-18T20:55:32Z | |
dc.date.issued | 2016 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Background: Psoriasis is associated with chronic obstructive pulmonary disease. There is no study on the spirometric pulmonary function testing in patients with psoriasis. Objective: The aim of this study was to compare the spirometric parameters in patients with psoriasis and controls. Methods: Ninety-six patients with psoriasis and 60 sex- and age-matched control subjects were included in this study. Spirometric pulmonary function testing, including percent forced vital capacity (FVC%), percent forced expiratory volume in the 1st second (FEV1%), forced expiratory flow at 25-75% of FVC (FEF25-75%), and FEV1/FVC ratio, was performed in all study subjects. Results: The mean FEV1/FVC ratio and FEF25-75% were significantly lower in the psoriasis patients than in the controls (82.4 +/- 6.3 vs. 90.7 +/- 10.7, p < 0.001, and 86.7 +/- 24.2 vs. 94.8 +/- 23.0, p = 0.04, respectively). Both FEV1/FVC ratio and FEF25-75% were significantly associated with the presence of psoriasis (p < 0.001 and p = 0.029, respectively). Conclusion: Psoriasis patients had lower mean FEV1/FVC ratios and FEF25-75%, compared with the control subjects. FEV1/FVC and FEF25-75% are independently associated with the presence of psoriasis. (C) 2017 S. Karger AG, Basel | en_US |
dc.identifier.doi | 10.1159/000456032 | |
dc.identifier.endpage | 667 | en_US |
dc.identifier.issn | 1018-8665 | |
dc.identifier.issn | 1421-9832 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 28226320 | en_US |
dc.identifier.scopus | 2-s2.0-85013639276 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 664 | en_US |
dc.identifier.uri | https://doi.org/10.1159/000456032 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/11897 | |
dc.identifier.volume | 232 | en_US |
dc.identifier.wos | WOS:000400358400005 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Karger | en_US |
dc.relation.ispartof | Dermatology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Psoriasis | en_US |
dc.subject | Chronic obstructive pulmonary disease | en_US |
dc.subject | Spirometry | en_US |
dc.subject | Pulmonary function | en_US |
dc.title | Impaired Pulmonary Function in Patients with Psoriasis | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1